Which group of individuals must be notified by the consultant pharmacist about irregularities found in a resident's medication regimen?

• A. DON and Medical Director
• B. DON, Medical Director, and attending physician
• C. Attending physician and family
• D. Attending physician

Answer: (B)

The main idea here is who must be alerted when a consultant pharmacist finds problems with a resident’s medicines. In a long‑term care setting, medication issues need action from both medical and nursing leadership as well as the clinician who makes prescribing decisions. The attending physician is the one who can adjust, change, or stop medications based on the pharmacist’s findings. The Medical Director provides oversight of the facility’s medical program, ensuring that any changes fit overall medical policy and standards of care. The Director of Nursing coordinates nursing care and medication administration, ensuring that the plan is implemented on the floor and monitored for safety. Together, this trio ensures proper evaluation, timely action, and appropriate documentation, meeting safety and regulatory expectations. Notifying a family or excluding the attending physician would either miss a critical prescribing input or omit essential medical and nursing oversight needed to manage and monitor the resident’s regimen.